|
🐜
|
Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes
14 auth.
J. Kleinnijenhuis,
J. Quintin,
F. Preijers,
L. Joosten,
D. Ifrim,
Sadia Saeed,
C. Jacobs,
J. van Loenhout,
D. D. de Jong,
H. Stunnenberg,
...
R. Xavier,
J. V. D. van der Meer,
R. van Crevel,
M. Netea
|
10 |
2012 |
10
🐜
|
|
🐜
|
NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis
11 auth.
G. Ferwerda,
S. Girardin,
B. Kullberg,
L. Le Bourhis,
D. D. de Jong,
Dennis M. L. Langenberg,
...
R. van Crevel,
G. Adema,
T. Ottenhoff,
J. V. D. van der Meer,
M. Netea
|
8 |
2005 |
8
🐜
|
|
🐜
|
High density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis
181 auth.
P. Goyette,
G. Boucher,
D. Mallon,
E. Ellinghaus,
L. Jostins,
Hailiang Huang,
S. Ripke,
Elena S. Gusareva,
V. Annese,
S. Hauser,
J. Oksenberg,
I. Thomsen,
S. Leslie,
C. Abraham,
J. Achkar,
...
L. Amininejad,
A. Ananthakrishnan,
V. Andersen,
C. Anderson,
J. Andrews,
G. Aumais,
L. Baidoo,
R. Baldassano,
T. Balschun,
P. Bampton,
M. Barclay,
J. Barrett,
T. Bayless,
J. Bethge,
J. Bis,
A. Bitton,
S. Brand,
S. Brant,
C. Büning,
Angela C. Chew,
Judy H. Cho,
I. Cleynen,
A. Cohain,
A. Croft,
M. Daly,
Mauro D’Amato,
S. Danese,
D. D. de Jong,
M. De Vos,
G. Denapiene,
L. Denson,
Kathy L. Devaney,
O. Dewit,
R. D'Incà,
Marla Dubinsky,
R. Duerr,
C. Edwards,
D. Ellinghaus,
J. Essers,
L. Ferguson,
Eleonora A. M. Festen,
P. Fleshner,
T. Florin,
D. Franchimont,
A. Franke,
K. Fransén,
R. Gearry,
Michel Georges,
C. Gieger,
J. Glas,
Todd Green,
A. Griffiths,
S. Guthery,
H. Hakonarson,
J. Halfvarson,
K. Hanigan,
T. Haritunians,
A. Hart,
C. Hawkey,
N. Hayward,
M. Hedl,
P. Henderson,
Xinli Hu,
Hailiang Huang,
Ken Y. Hui,
M. Imieliński,
A. Ippoliti,
L. Jonaitis,
T. Karlsen,
N. Kennedy,
M. Khan,
G. Kiudelis,
S. Kugathasan,
L. Kupčinskas,
A. Latiano,
D. Laukens,
I. Lawrance,
James C. Lee,
C. Lees,
M. Leja,
Johan van Limbergen,
P. Lionetti,
J. Liu,
É. Louis,
G. Mahy,
J. Mansfield,
D. Massey,
C. Mathew,
D. McGovern,
R. Milgrom,
M. Mitrovič,
G. Montgomery,
C. Mowat,
W. Newman,
Aylwin Ng,
S. Nikolaus,
Kaida Ning,
M. Nöthen,
I. Oikonomou,
O. Palmieri,
M. Parkes,
A. Phillips,
C. Ponsioen,
U. Potočnik,
N. Prescott,
D. Proctor,
G. Radford-Smith,
J. Rahier,
S. Raychaudhuri,
M. Regueiro,
F. Rieder,
J. Rioux,
S. Ripke,
R. Roberts,
R. Russell,
J. Sanderson,
M. Sans,
J. Satsangi,
E. Schadt,
S. Schreiber,
L. P. Schumm,
R. Scott,
Mark Seielstad,
Y. Sharma,
M. Silverberg,
L. Simms,
J. Skieceviciene,
S. Spain,
A. Steinhart,
J. Stempak,
L. Stronati,
Jurgita Šventoraitytė,
S. Targan,
K. Taylor,
A. T. Velde,
E. Théâtre,
L. Torkvist,
M. Tremelling,
A. E. van der Meulen,
S. van Sommeren,
E. Vasiliauskas,
S. Vermeire,
H. Verspaget,
T. Walters,
Kai Wang,
Ming-Hsi Wang,
R. Weersma,
Zhi Wei,
D. Whiteman,
C. Wijmenga,
D. Wilson,
J. Winkelmann,
R. Xavier,
S. Zeissig,
Bin Zhang,
Clarence K. Zhang,
Hu Zhang,
Wei Zhang,
Hongyu Zhao,
Z. Zhao,
K. van Steen,
J. Barrett,
J. Traherne,
M. Carrington,
V. Kosmoliaptsis,
J. Rioux
|
8 |
2014 |
8
🐜
|
|
🐜
|
Nucleotide-Binding Oligomerization Domain-2 Modulates Specific TLR Pathways for the Induction of Cytokine Release 1
12 auth.
M. Netea,
G. Ferwerda,
D. D. de Jong,
T. Jansen,
L. Jacobs,
Matthijs Kramer,
...
T. Naber,
J. Drenth,
S. Girardin,
Bart Jan Kullberg,
G. Adema,
J. V. D. van der Meer
|
8 |
2005 |
8
🐜
|
|
🐜
|
NOD2 mediates anti‐inflammatory signals induced by TLR2 ligands: implications for Crohn's disease
8 auth.
M. Netea,
B. Kullberg,
D. D. de Jong,
B. Franke,
T. Sprong,
T. Naber,
...
J. Drenth,
J. van der Meer
|
7 |
2004 |
7
🐜
|
|
🐜
|
Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort
16 auth.
R. Weersma,
P. Stokkers,
A. V. van Bodegraven,
R. V. van Hogezand,
H. Verspaget,
D. D. de Jong,
C. J. van der Woude,
B. Oldenburg,
R. Linskens,
E. Festen,
...
G. van der Steege,
D. Hommes,
J. Crusius,
C. Wijmenga,
I. Nolte,
G. Dijkstra
|
7 |
2008 |
7
🐜
|
|
🐜
|
Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2
10 auth.
T. Plantinga,
T. Crișan,
M. Oosting,
F. L. van de Veerdonk,
D. D. de Jong,
D. Philpott,
...
J. van der Meer,
S. Girardin,
L. Joosten,
M. Netea
|
7 |
2011 |
7
🐜
|
|
🐜
|
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
15 auth.
M. Coenen,
D. D. de Jong,
C. V. van Marrewijk,
L. Derijks,
S. Vermeulen,
D. Wong,
O. Klungel,
A. Verbeek,
P. Hooymans,
W. Peters,
...
R. T. te Morsche,
W. Newman,
H. Scheffer,
H. Guchelaar,
B. Franke
|
7 |
2015 |
7
🐜
|
|
🐜
|
Ustekinumab for Crohn’s Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study
15 auth.
V. Biemans,
A. E. van der Meulen - de Jong,
C. J. van der Woude,
M. Löwenberg,
G. Dijkstra,
B. Oldenburg,
N. D. de Boer,
S. van der Marel,
A. Bodelier,
J. Jansen,
...
J. Haans,
R. Theeuwen,
D. D. de Jong,
M. Pierik,
F. Hoentjen
|
7 |
2019 |
7
🐜
|
|
🐜
|
Association Between Toll‐like Receptor 4 and Inflammatory Bowel Disease
11 auth.
L. Oostenbrug,
J. Drenth,
D. D. de Jong,
I. Nolte,
E. Oosterom,
H. V. van Dullemen,
...
K. van der Linde,
G. T. te Meerman,
G. van der Steege,
J. Kleibeuker,
P. Jansen
|
7 |
2005 |
7
🐜
|
|
🐜
|
Clinical Outcomes Following a Switch from Remicade® to the Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: A Prospective Observational Cohort Study.
7 auth.
L. Smits,
L. Derikx,
D. D. de Jong,
R. Boshuizen,
A. V. van Esch,
J. Drenth,
...
F. Hoentjen
|
7 |
2016 |
7
🐜
|
